AHR · American Healthcare REIT, Inc.
$57.16
+0.11 (+0.19%)
At close · Aug 26
Market Cap
$12.25B
Shares
218.00M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$57.16
Open$57.13
Day$56.80–57.46
52W close$40.18–57.72
Avg vol 30d2.8M
Short int29.5M · 13.5% float · 8.2d
Short vol56%
Last earningsAug 7, 2026
DataFeb 2024–Aug 2026
Filing10-Q · Aug 7
Up next
Next earnings call
Nov 6, 2026
Est · unconfirmed
· in 10 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 7, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Strong Buy
Momentum
Strong
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Low
Market backdrop
VIX 15.2 · calm
Equity put/call 0.64
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+13%
above
Price vs 50-day avg
+5%
above
RSI (14)
61
neutral
MACD trend
Positive
52-week position
97%
near high
Momentum
relative strength
1-month return
−1%
trailing
6-month return
+10%
trailing
YTD return
+21%
this year
Relative strength
−3%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $54 › 200d $50 — 50d above 200d
Institutional flow
Accumulating
+10% holders QoQ · +98 funds added
Insider flow
Distributing
Net -$1.4M over 90 days · 100% sells
Short interest
Rising
13.53% of float · ▲ +33.2% MoM · 8.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
569 holders — near 2-yr high, broad support
Squeeze score
74
high risk · 0–100
Fundamentals
Revenue growth
+9%
Y/Y
EPS growth
+245%
Y/Y
Valuation
P/E 81.4
rich
Balance sheet
$870.7M
net debt
Quant / Vol
risk profile
Volatility
26%
annualized · 1-yr
Max drawdown
−14%
past year
ATR
2.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Aug 6, 2026
Full Year 2026
Total Portfolio SS NOI Growth
Non-GAAP
Raised
11% – 13%
May 7, 2026
9% – 12%
changed to
Aug 6, 2026
11% – 13%
ISHC Same-Store NOI Growth
Non-GAAP
Raised
13% – 16%
May 7, 2026
11% – 15%
changed to
Aug 6, 2026
13% – 16%
SHOP Same-Store NOI Growth
Non-GAAP
Raised
18% – 21%
May 7, 2026
15% – 19%
changed to
Aug 6, 2026
18% – 21%
FY 2026
General and administrative expenses
Raised
$74M – $78M
May 7, 2026
$68M – $74M
changed to
Aug 6, 2026
$74M – $78M
Interest expense
Lowered
$75M – $79M
May 7, 2026
$82M – $86M
changed to
Aug 6, 2026
$75M – $79M
New development starts and on-going development projects funding
Raised
$150M – $170M
May 7, 2026
$100M – $120M
changed to
Aug 6, 2026
$150M – $170M
Total Portfolio Same-Store NOI Growth
Non-GAAP
Raised
11% – 13%
May 7, 2026
9% – 12%
changed to
Aug 6, 2026
11% – 13%
Triple-Net Leased Properties Same-Store NOI Growth
Non-GAAP
Maintained
2% – 3%
May 7, 2026
2% – 3%
changed to
Aug 6, 2026
2% – 3%
Other income, net
Maintained
$5M – $8M
May 7, 2026
$5M – $8M
changed to
Aug 6, 2026
$5M – $8M
Funding for new development starts and on-going development proj
Raised
$150M – $170M
May 7, 2026
$100M – $120M
changed to
Aug 6, 2026
$150M – $170M
Prior guidance
period ended
· from the 8-K filed Nov 6, 2025
Same-Store NOI growth
· year ending December 31, 2025
13% – 15%
Normalized Funds from Operations (NFFO) per diluted share
· year ending December 31, 2025
$1.69 – $1.72
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+13%
Bullish
Price vs 50-day avg
+5%
Bullish
RSI (14)
61
Neutral
MACD trend
Positive
Bullish
52-week position
97%
Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $54 › 200d $50 — 50d above 200d
Institutional flow
Accumulating
+10% holders QoQ · +98 funds added
Insider flow
Distributing
Net -$1.4M over 90 days · 100% sells
Short interest
Rising
13.53% of float · ▲ +33.2% MoM · 8.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
569 holders — near 2-yr high, broad support
Price context
position in its 52-week range
Range low $40
Now $57 · 97%
Range high $58
vs 200-day avg +13%
vs 50-day avg +5%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | 124.99M | Three Months Ended June 30, 2026 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP EBITDA $122.16M
-$892K Income from unconsolidated entities
-$486K Straight line rent and amortization of above/below market leases
+$5.77M Non-cash impact of changes to equity instruments
+$2.79M Transaction, transition and restructuring costs
-$5.65M Gain on dispositions of real estate investments, net
+$12K Amortization of closing costs — debt security investment
-$75K Foreign currency gain
-$357K Gain in fair value of derivative financial instruments
+$1.72M Impairment of real estate investments
= Adjusted EBITDA $124.99M
|
|||
| Average operator Occupancy (Triple-Net Leased Properties) | 90.5% | Q2 2026 | — |
| Cash NOI non-GAAP | 274.22M | Six Months Ended June 30, 2026 | — |
|
|
|||
| Consolidated average Occupancy (ISHC) | 89.5% | Q2 2026 | — |
| Consolidated average Occupancy (SHOP) | 88.8% | Q2 2026 | — |
| Ending Occupancy (Outpatient Medical) | 88.4% | Q2 2026 | — |
| NAREIT FFO attributable to controlling interest | 188.33M | Six Months Ended June 30, 2026 | — |
| NAREIT FFO per common share attributable to controlling interest — diluted | $0.99 | Six Months Ended June 30, 2026 | — |
|
|
|||
| Net operating income | 262.74M | Six Months Ended June 30, 2026 | — |
| Normalized FFO attributable to controlling interest non-GAAP | 200M | Six Months Ended June 30, 2026 | — |
|
|
|||
| Normalized FFO per common share attributable to controlling interest — diluted non-GAAP | $1.05 | Six Months Ended June 30, 2026 | — |
|
|
|||
| Normalized FFO per share - diluted non-GAAP | $0.54 | Q2 2026 | — |
| Pro-Rata Annualized Cash NOI (Total) non-GAAP | $571.84M | Q2 2026 | — |
| Same-Store NOI (ISHC) non-GAAP | $71.35M | Q2 2026 | — |
| Same-Store NOI (Outpatient Medical) non-GAAP | $17.39M | Q2 2026 | — |
| Same-Store NOI (SHOP) non-GAAP | $16.09M | Q2 2026 | — |
| Same-Store NOI (Total Portfolio) non-GAAP | $112.29M | Q2 2026 | — |
| Same-Store NOI (Triple-Net Leased Properties) non-GAAP | $7.46M | Q2 2026 | — |
| Same-Store properties (ISHC) | 115 | For the Six Months Ended June 30, 2026 | — |
| Same-Store properties (OM) | 65 | For the Six Months Ended June 30, 2026 | — |
| Same-Store properties (SHOP) | 64 | For the Six Months Ended June 30, 2026 | — |
| Same-Store properties (Triple-Net Leased Properties) | 17 | For the Six Months Ended June 30, 2026 | — |
| Total Portfolio Same-Store NOI Growth | 12.7% | Six Months Ended June 30, 2026 Relative to Six Months Ended June | — |
|
|
|||
| Trailing 12-months Retention (OM) | 65.2% | Q2 2026 | — |
| Cash NOI Margin non-GAAP | 15.6% | Q1 2026 | — |
| ISHC Same-Store NOI non-GAAP | 67.68M | Q1 2026 | — |
| ISHC Same-Store NOI Growth non-GAAP | 13% | Full Year 2026 | -29.3% |
|
|
|||
| ISHC Same-Store NOI Margin non-GAAP | 20.1% | Q1 2026 | — |
| Net Debt non-GAAP | 1.37B | Q1 2026 | — |
| NFFO per diluted share non-GAAP | $2.06 | Full Year 2026 | — |
| Outpatient Medical Cash NOI non-GAAP | $20.29M | Q1 2026 | — |
| Outpatient Medical Cash NOI Margin non-GAAP | 62.1% | Q1 2026 | — |
| Outpatient Medical Ending Occupancy | 88.9% | Q1 2026 | — |
| Outpatient Medical Revenue per square foot | $30.7 | Q1 2026 | — |
| Outpatient Medical Same-Store NOI non-GAAP | $17.25M | Q1 2026 | — |
|
|
|||
| Outpatient Medical Same-Store NOI Growth non-GAAP | 1% | Full Year 2026 | -52.4% |
|
|
|||
| Outpatient Medical Same-Store NOI Margin non-GAAP | 62.8% | Q1 2026 | — |
| Q1 2026 Annualized Cash NOI non-GAAP | 520.8M | Q1 2026 | — |
| Q1 2026 Cash NOI non-GAAP | 130.2M | Q1 2026 | — |
| Same-Store NOI Margin non-GAAP | 20.1% | Q1 2026 | — |
| SHOP Cash NOI non-GAAP | $25.78M | Q1 2026 | — |
| SHOP ExPOR | $4,247 | Q1 2026 | — |
| SHOP RevPOR | $5,600 | Q1 2026 | — |
|
|
|||
| SHOP Same-Store NOI Growth non-GAAP | 17% | Full Year 2026 | -32.5% |
|
|
|||
| SHOP Same-Store NOI Margin non-GAAP | 20.6% | Q1 2026 | — |
| SHOP Same-Store RevPOR | $5,281 | Q1 2026 | — |
| Total average Occupancy | 89.9% | Q1 2026 | — |
| Total Portfolio Same-Store NOI non-GAAP | 95.46M | Q1 2026 | — |
|
|
|||
| Total Portfolio SS NOI Growth non-GAAP | 10.5% | Full Year 2026 | — |
| Total properties/campuses | 323 | Q1 2026 | — |
| Triple-Net Leased Properties Cash NOI non-GAAP | $8.79M | Q1 2026 | — |
| Triple-Net Leased Properties Cash NOI Margin non-GAAP | 90.2% | Q1 2026 | — |
| Triple-Net Leased Properties Same-Store NOI non-GAAP | $7.47M | Q1 2026 | — |
|
|
|||
| Triple-Net Leased Properties Same-Store NOI Growth non-GAAP | 2.5% | Full Year 2026 | +400.0% |
|
|
|||
| Triple-Net Leased Properties Same-Store NOI Margin non-GAAP | 92.5% | Q1 2026 | — |
| Integrated Senior Health Campuses Same-Store NOI non-GAAP | 248.58M | FY 2025 | — |
| ISHC Average occupancy | 89.3% | FY 2025 | — |
| ISHC occupancy | 90.1% | Q4 2025 | — |
| NAREIT FFO per share—diluted non-GAAP | $1.76 | FY 2025 | — |
| Normalized FFO per share—diluted non-GAAP | $1.72 | FY 2025 | — |
| OM Ending occupancy | 88.9% | FY 2025 | — |
| OM occupancy | 88.9% | Q4 2025 | — |
| OM Same-Store ending occupancy | 92% | FY 2025 | — |
| OM Same-Store NOI growth non-GAAP | 2.1% | FY 2025 | — |
| OM Same-Store NOI per square foot | $21.07 | FY 2025 | — |
| Same-Store properties | 246 | FY 2025 | — |
| SHOP Average occupancy | 87.1% | FY 2025 | — |
| SHOP occupancy | 89.1% | Q4 2025 | — |
| SHOP Same-Store NOI non-GAAP | 46.49M | FY 2025 | — |
| SHOP Same-Store occupancy | 88.3% | FY 2025 | — |
| SHOP Same-Store revenue | 56.97M | Q4 2025 | — |
| Total beds/units (ISHC) | 14,955 | Q4 2025 | — |
| Total beds/units (SHOP) | 7,188 | Q4 2025 | — |
| Total GLA (OM) | 3.69M | Q4 2025 | — |
| Total Portfolio Same-Store revenue | 1.69B | FY 2025 | — |
| Total properties | 319 | FY 2025 | — |
| Total properties (ISHC) | 147 | Q4 2025 | — |
| Total properties (OM) | 71 | Q4 2025 | — |
| Total properties (Same-Store) | 246 | Q4 2025 | — |
| Total properties (SHOP) | 83 | Q4 2025 | — |
| Total properties (Total Portfolio) | 319 | Q4 2025 | — |
| Total properties (Triple-Net Leased) | 18 | Q4 2025 | — |
| Total Same-Store NOI | $397.91M | FY 2025 | — |
| Triple-Net Leased occupancy | 89.2% | Q4 2025 | — |
| Triple-Net Leased Properties Average operator occupancy | 89% | FY 2025 | — |
| Triple-Net Leased Properties Same-Store revenue | 7.9M | Q4 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
REIT - Healthcare Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AHR
this stock
American Healthcare REIT, Inc.
|
$12.25B | +21.5% | +9.1% | 81.4 | 13.5% |
|
WELL
Welltower Inc.
|
$169.43B | +30.1% | +35.6% | 119.4 | 2.5% |
|
VTR
Ventas, Inc.
|
$47.95B | +20.8% | +18.5% | 173.1 | 4.6% |
|
DOC
Healthpeak Properties, Inc.
|
$14.94B | +34.2% | +4.5% | 61.9 | 3.3% |
|
OHI
Omega Healthcare Investors Inc
|
$14.25B | +5.9% | +13.2% | 16.7 | 4.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AHR | +3.6% | -0.6% | +9.7% | +2.8% | +21.5% |
| SPY | -0.4% | +5.0% | +12.4% | +2.6% | +12.3% |
| vs SPY | +3.9% | -5.7% | -2.8% | +0.3% | +9.1% |
Capital returns
Latest dividend
$0.25
/ share · ex Jun 30, 2026
Paid (TTM)
$1.00
/ share · 4 payouts
Dividend yield (TTM, derived)
1.75%
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
1632970
CUSIP
398182303
13F (30d)
447 filings
446 filers
Visit website
Investor relations